
This gallery contains 1 photo.
We are pleased to announce the addition of Timothy W. Robison, PhD, DABT, who has 29 years of experience at the US Food… read more
ToxStrategies’ scientists Jennifer Bare, Mandie Kramer, and Susan Borghoff are excited share their new paper on consumer product exposure to vinyl acetate monomer (VAM). The team partnered with the Vinyl Acetate Council, who provided funding for the research, and analytical chemists and toxicologists from LyondellBasell Industries, who developed methods for determining VAM in a variety of consumer products. ToxStrategies subsequently modeled consumer exposure to a variety of household products containing residual VAM using EPA’s Consumer Exposure Model and RIVM’s ConsExpo. The study marks a significant contribution to the field, as it both presents an analytical methodology for detecting VAM in consumer products and demonstrates that, for the products evaluated, potential VAM exposure is less than acute and chronic health thresholds for the general public, based on the modeled exposure scenarios and assumptions.
The open access publication in the Journal of Exposure Science & Environmental Epidemiology is free to read and download, here:
In the United States, the most common childhood central nervous system cancer is pediatric low-grade glioma, but there are no standardized coding definitions to easily identify these patients. On Friday, May 16, 2025, Mina Suh, Sue Pastula, and collaborators from CBTRUS and Duke University will present a study on developing coding definitions and describing pediatric patients with glioma. Please join us!
BlueRidge Life Sciences Pharmaceutical Commercialization’s Dr. Naomi Sacks’s work published in Obesity Science & Practice on behalf of The Obesity Society was recently… read more
ToxStrategies is pleased to announce that nationally recognized toxicologist Dr. Brent Finley has joined our firm as an Executive Vice President. Dr. Finley… read more